US stops AstraZeneca vaccine production at Baltimore plant: Report
The US government on Saturday stopped a Baltimore manufacturing plant that ruined 15 million doses of Johnson & Johnson's Covid-19 vaccine from making the vaccine developed by AstraZeneca Plc, the New York Times reported. J&J said in a statement that it was "assuming full responsibility regarding the manufacturing of drug substance for its Covid-19 vaccine at the Emergent BioSolutions Inc. Bayview facility."
Admin
0
7
The US government on Saturday stopped a Baltimore manufacturing plant that ruined 15 million doses of Johnson & Johnson's Covid-19 vaccine from making the vaccine developed by AstraZeneca Plc, the New York Times reported. J&J said in a statement that it was "assuming full responsibility regarding the manufacturing of drug substance for its Covid-19 vaccine at the Emergent BioSolutions Inc. Bayview facility." 
